Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
La Ricerca in Clinica E in Laboratorio
|
October 1, 1985
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy
A R Zanetti, P Ferroni, M Colombo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 19, 2017
Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study
K Khair, M G Mazzucconi, R Parra, et al.
American Journal of Hematology
|
December 1, 1988
Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs
P M Mannucci, A Gringeri, M Morfini, et al.
ACS Nano
|
September 17, 2024
Monomer Composition as a Mechanism to Control the Self-Assembly of Diblock Oligomeric Peptide-Polymer Amphiphiles
Benjamin P Allen, Sabila K Pinky, Emily E Beard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2004
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri, S von Mackensen, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 15, 2007
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
J Teitel, E Berntorp, P Collins, et al.
British Journal of Haematology
|
January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group
P M Mannucci, A Gringeri, G Savidge, et al.
Archives of Internal Medicine
|
June 1, 1989
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs
P M Mannucci, A R Zanetti, A Gringeri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 25, 1999
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy
D Zagury, H Lecoq, I Gervi, et al.
Blood
|
July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study
D B Brettler, P M Mannucci, A Gringeri, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
La Ricerca in Clinica E in Laboratorio
|
October 1, 1985
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy
A R Zanetti, P Ferroni, M Colombo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 19, 2017
Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study
K Khair, M G Mazzucconi, R Parra, et al.
American Journal of Hematology
|
December 1, 1988
Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs
P M Mannucci, A Gringeri, M Morfini, et al.
ACS Nano
|
September 17, 2024
Monomer Composition as a Mechanism to Control the Self-Assembly of Diblock Oligomeric Peptide-Polymer Amphiphiles
Benjamin P Allen, Sabila K Pinky, Emily E Beard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2004
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri, S von Mackensen, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 15, 2007
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
J Teitel, E Berntorp, P Collins, et al.
British Journal of Haematology
|
January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group
P M Mannucci, A Gringeri, G Savidge, et al.
Archives of Internal Medicine
|
June 1, 1989
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs
P M Mannucci, A R Zanetti, A Gringeri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 25, 1999
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy
D Zagury, H Lecoq, I Gervi, et al.
Blood
|
July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study
D B Brettler, P M Mannucci, A Gringeri, et al.
Page
of 13